Phathom Pharmaceuticals Inc (NAS:PHAT)
$ 18.37 -0.57 (-3.01%) Market Cap: 1.25 Bil Enterprise Value: 1.19 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

Q4 2023 Phathom Pharmaceuticals Inc Earnings Call Transcript

Mar 07, 2024 / 01:30PM GMT
Release Date Price: $9.09 (-6.58%)
Operator

Hello, and welcome to the Phathom Pharmaceuticals Fourth Quarter and Full Year 2023 earnings conference call. At this time, all participants are in a listen only mode. After the presentation there will be a question and answer session to ask a question. During the session, you will need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one again. Please be advised today's conference is being recorded. With that, I would like to turn the conference over to Eric separately, SatCon's Head of Investor Relations. Please go ahead.

Eric Sciorilli
Phathom Pharmaceuticals, Inc. - Head of IR

Thank you, operator. Hello, everyone, and thank you for joining us this morning to discuss Falcon's Fourth Quarter and Full Year 2023 results. This morning's presentation will include remarks from Terrie Curran, our President and CEO, Martin Gilligan, our Chief Commercial Officer, and Molly Henderson, our Chief Financial Officer, renewable C, our Chief Operating Officer, will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot